OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
May 12, 2023
Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
May 04, 2023
Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.
May 03, 2023
The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.
The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.
The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.
May 02, 2023
Guidance for GMP manufacture of emerging therapies has evolved to accommodate innovation and the broader spectrum of products in development, but greater harmonization is still needed.
Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing.
The ROSS Inline Ultra High Shear Sanitary Mixer Model HSM-715XSUHD-250 is designed to deliver exceptional dispersion, emulsification, and homogenization at high throughput.
Emerson’s Rosemount 319 Flushing Ring comes in both traditional and compact sizes.